Kvaloy S - Search Results

1

The CUP trial: a randomized study analyzing the efficacy of high dose therapy and purging in low-grade non-Hodgkin's lymphoma (NHL).

Schouten HC, Kvaloy S, Sydes M, Qian W, Fayers PM. Schouten HC, et al. Among authors: kvaloy s. Ann Oncol. 2000;11 Suppl 1:91-4. Ann Oncol. 2000. PMID: 10707787 Clinical Trial.

2

High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Blood and Marrow Transplantation and the United Kingdom Lymphoma Group.

Sweetenham JW, Santini G, Qian W, Guelfi M, Schmitz N, Simnett S, Nagler A, Holte H, Kvaloy S, Bruzzi P, Goldstone AH. Sweetenham JW, et al. Among authors: kvaloy s. J Clin Oncol. 2001 Jun 1;19(11):2927-36. doi: 10.1200/JCO.2001.19.11.2927. J Clin Oncol. 2001. PMID: 11387366 Clinical Trial.

3

Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model.

Hollender A, Kvaloy S, Nome O, Skovlund E, Lote K, Holte H. Hollender A, et al. Among authors: kvaloy s. Ann Oncol. 2002 Jul;13(7):1099-107. doi: 10.1093/annonc/mdf175. Ann Oncol. 2002. PMID: 12176790 Free article.

4

Clinical stage I and II Hodgkin's disease: long-term results of therapy without laparotomy. Experience at one institution.

Abrahamsen AF, Hannisdal E, Nome O, Holte H, Hager B, Langholm R, Kvaløy S. Abrahamsen AF, et al. Among authors: kvaloy s. Ann Oncol. 1996 Feb;7(2):145-50. doi: 10.1093/oxfordjournals.annonc.a010541. Ann Oncol. 1996. PMID: 8777170 Free article. Clinical Trial.

5

CHOP versus MACOP-B in aggressive lymphoma--a Nordic Lymphoma Group randomised trial.

Jerkeman M, Anderson H, Cavallin-Ståhl E, Dictor M, Hagberg H, Johnson A, Kaasa S, Kvaløy S, Sundström C, Akerman M. Jerkeman M, et al. Among authors: kvaloy s. Ann Oncol. 1999 Sep;10(9):1079-86. doi: 10.1023/a:1008392528248. Ann Oncol. 1999. PMID: 10572606 Free article. Clinical Trial.

6

Long-term risk of second malignancy after treatment of Hodgkin's disease: the influence of treatment, age and follow-up time.

Foss Abrahamsen A, Andersen A, Nome O, Jacobsen AB, Holte H, Foss Abrahamsen J, Kvaløy S. Foss Abrahamsen A, et al. Among authors: kvaloy s. Ann Oncol. 2002 Nov;13(11):1786-91. doi: 10.1093/annonc/mdf289. Ann Oncol. 2002. PMID: 12419752 Free article.

7

Central nervous system occurrence in elderly patients with aggressive lymphoma and a long-term follow-up.

Björkholm M, Hagberg H, Holte H, Kvaloy S, Teerenhovi L, Anderson H, Cavallin-Ståhl E, Myhre J, Pertovaara H, Ost A, Nilsson B, Osby E. Björkholm M, et al. Among authors: kvaloy s. Ann Oncol. 2007 Jun;18(6):1085-9. doi: 10.1093/annonc/mdm073. Epub 2007 Mar 15. Ann Oncol. 2007. PMID: 17363838 Free article. Clinical Trial.

8

High-dose therapy supported with immunomagnetic purged autologous bone marrow in high-grade B cell non-Hodgkin's lymphoma.

Blystad A, Kvalheim G, Torlakovic E, Holte H, Jacobsen E, Beiske K, Vâlerhaugen H, Lenschow E, Kvaloy S. Blystad A, et al. Among authors: kvaloy s. Bone Marrow Transplant. 1999 Oct;24(8):865-72. doi: 10.1038/sj.bmt.1701990. Bone Marrow Transplant. 1999. PMID: 10516698

9

Stage I high-grade non-Hodgkin's lymphoma.

Lote K, Holte H, Nome O, Langholm R, Kvaløy S. Lote K, et al. Among authors: kvaloy s. Acta Oncol. 2000;39(7):865-72. doi: 10.1080/028418600750063631. Acta Oncol. 2000. PMID: 11145446

10

Immunomagnetic purging of lymphoma cells from autografts.

Kvalheim G, Holte H, Jakobsen E, Kvaloy S. Kvalheim G, et al. Among authors: kvaloy s. J Hematother. 1996 Oct;5(5):561-2. doi: 10.1089/scd.1.1996.5.561. J Hematother. 1996. PMID: 8938530

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

130 results

Search Page